Compulsory licensing is a negotiating tool but not a panacea
This is an interesting column from yesterday’s Indian Express on pharma compulsory licensing as a negotiating tool to achieve tiered pricing of innovative products. It is more nuanced and thoughtful than most writing on the subject and points out that generics will meetonly the needs of the middle class in the absence of universal health …
Compulsory licensing is a negotiating tool but not a panacea Read More »